Baxter Sues J&J For Violating Floseal Patents

Law360, Los Angeles (January 23, 2014, 6:32 PM EST) -- Global health care company Baxter International Inc. hit Johnson & Johnson Inc. with a patent infringement lawsuit in Illinois federal court Thursday, accusing the medical device giant of violating six patents protecting Baxter’s biosurgery products, including Floseal, used to control bleeding during surgery.

The lawsuit raises allegations that Johnson & Johnson manufactures, imports, assembles and markets delivery devices for hemostasis, including its SurgiFlo family of products, which directly compete with Baxter’s biosurgery products. Floseal and SurgiFlo are indicated for use in surgical procedures as an adjunct...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.